Wednesday, March 19, 2014

Study Points to Possible Blood Test For Memory Decline, Alzheimer's

A new study identified a set of 10 compounds in the blood that might be used to identify older adults at risk for developing memory deficits or Alzheimer s disease. More research is needed to confirm the findings, but the study suggests one possible approach for the early identification and treatment of cognitive decline.....

.....Dr. Howard Federoff of Georgetown University Medical Center and his colleagues decided to search for biomarkers of early-stage Alzheimer's disease in circulating blood. They enrolled 525 healthy adults, ages 70 and older, in a 5-year observational study. The research was funded in part by NIH's National Institute on Aging (NIA). Results appeared online on March 9, 2014, inNature Medicine.......

......"The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention," Federoff says. "Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics." The researchers note that the biomarker panel would require further validation in larger, diverse populations before it could be used clinically.

Tuesday, March 18, 2014

New exposé on chronic illness


"...This story has all the elements of intrigue, a relatively complex plot, a David vs. Goliath conflict, insights into tragically ill people, the rise and fall of the extremely wealthy, and insights into the US scientific community."  (From the book jacket)

On July 22, 2009, a special meeting was held with twenty-four leading scientists at the National Institutes of Health to discuss early findings that a newly discovered retrovirus was linked to chronic fatigue syndrome (CFS), prostate cancer, lymphoma, and eventually neurodevelopmental disorders in children.When Dr. Judy Mikovits finished her presentation the room was silent for a moment, then one of the scientists said, "Oh my God!" The resulting investigation would be like no other in science.

For Dr. Mikovits, a twenty-year veteran of the National Cancer Institute, this was the midpoint of a five-year journey that would start with the founding of the Whittemore-Peterson Institute for Neuro-Immune Disease at the University of Nevada, Reno, and end with her as a witness for the federal government against her former employer, Harvey Whittemore, for illegal campaign contributions to U.S. Senate Majority Leader Harry Reid.

On this journey Dr. Mikovits would face the scientific prejudices against CFS, wander into  the minefield that is autism, and through it all struggle to maintain her faith in God, the American justice system and the profession to which she had dedicated her life. This is a story for anybody interested in the promise and peril of science at the very highest levels in our country.

Read more, see a video: http://www.plaguethebook.com/

Saturday, March 15, 2014

Gut bacteria transplants can restore your health



By : Noubar AfeyanMar 14th 2014
 
Can you give an overview of what "microbiome-based" healthcare is?
About seven years ago, the tools that were first used to sequence the human genome were used to begin large-scale sequencing of the microorganisms in our guts and other parts of the body. That work soon indicated intriguing differences between people. For example, the collection of organisms prevalent in the guts of obese people was quite different to that within lean people, though it was not clear what was causal and what was correlative. In the past few years, more specific research has looked at the functional role these organism collections play.
Recent press attention has focused on a medical procedure called fecal microbial transplant (FMT). It has been used to treat infections of Clostridium difficile, which can be acquired through hospitalization and heavy antibiotic use. The procedure, which has been done as a kind of last resort, seems curative. When that was combined with the growing understanding of the organisms in the gut, a hypothesis emerged that organisms from a healthy donor might be able to "reboot" microbes in the gut.
What work is going on now?
Several groups, both in academia and industry, are collecting and combining organisms. Their results are beginning to show that restoring the health of a gut microbiome may well be a viable clinical procedure; not just with fecal transplants, but also more specific microbiome therapeutics.
Treating people with organisms taken from healthy guts is a methodology that is now being considered for several other diseases that appear to involve a disturbed state of the microbiome, such as inflammatory bowel disease. It could even be used to treat other things, which is unprecedented. Currently, there is no healthcare product that involves organism collections.
When we talk about the microbiome, we're talking about a vast system, aren't we?

Friday, March 14, 2014

Injectable Vit C book

I came across this book at the place where I get infusions. I intend to read it but have not yet.

Thursday, March 13, 2014

A new strain of Lyme Disease


"The diagnoses of Lyme disease based on clinical manifestations, serological findings and detection of infectious agents often contradict each other…"

Milford Hospital Pathologist Identifies New Strain of Lyme Disease by DNA Sequencing

International Report: New bacteria found in patient blood sample is undetectable in standard serology Lyme test, reports Milford Hospital pathologist

March 13, 2014 10:00 AM Eastern Daylight Time

MILFORD, Conn.--()--Patients with clinical Lyme disease may not be infected by the Lyme disease spirochete (bacteria), but in fact by other related bacteria, such as Borrelia miyamotoi and a new, as yet unnamed spirochete according to a paper just published this month in the International Journal of Molecular Sciences http://www.mdpi.com/1422-0067/15/3/4284/.

Int. J. Mol. Sci. 201415(3), 4284-4298; doi:10.3390/ijms15034284
Article

Detection of Borreliae in Archived Sera from Patients with Clinically Suspect Lyme Disease

1 Department of Pathology, Milford Hospital, 300 Seaside Ave., Milford, CT 06460, USA2 Therapeutic Research Foundation, Old Saybrook, CT 06475, USA
* Author to whom correspondence should be addressed.
Received: 27 January 2014; in revised form: 1 March 2014 / Accepted: 4 March 2014 / Published: 11 March 2014
(This article belongs to the Section Molecular Diagnostics)
PDF Full-text Download PDF Full-Text [2086 KB, uploaded 11 March 2014 11:45 CET]
Abstract: The diagnoses of Lyme disease based on clinical manifestations, serological findings and detection of infectious agents often contradict each other. We tested 52 blind-coded serum samples, including 20 pre-treatment and 12 post-treatment sera from clinically suspect Lyme disease patients, for the presence of residual Lyme disease infectious agents, using nested PCR amplification of a signature segment of the borrelial 16S ribosomal RNA gene for detection and direct DNA sequencing of the PCR amplicon for molecular validation. These archived sera were split from the samples drawn for the 2-tier serology tests performed by a CDC-approved laboratory, and are used as reference materials for evaluating new diagnostic reagents. Of the 12 post-treatment serum samples, we found DNA evidence of a novel borrelia of uncertain significance in one, which was also positive for the 2-tier serology test. The rest of the post-treatment sera and all 20 control sera were PCR-negative. Of the 20 pre-treatment sera from clinically suspect early Lyme disease patients, we found Borrelia miyamotoi in one which was 2-tier serology-negative, and a Borrelia burgdorferi in two—one negative and one positive for 2-tier serology. We conclude that a sensitive and reliable DNA-based test is needed to support the diagnosis of Lyme disease and Lyme disease-like borreliosis.


Sunday, March 9, 2014

An experiment in culturing Borrelia from blood

Peter Kemp has written to Facebook ME and Lyme forums, and to Co-Cure:

"Dear All, I've written-up an experiment that cultured blood from Lyme Borreliosis and M.E. patients for microscopy. There are photographs and videos which are the main data from the experiment.


This is the large font version suitable for printing (large page may take a while to download)

Many Thanks to all those that helped with the experiment."


Friday, March 7, 2014

Law Would Grant 'Safe Harbor' to Docs Who Follow Guidelines

From (c) Medscape, March 6, 2014

http://www.medscape.com/viewarticle/821588?src=wnl_edit_medn_wir&spon=34

You may need to establish a free account at Medscape to read the article there. I reprint here, for your benefit and easier access. Please note the copyright.

Physicians who are Medicare and Medicaid providers would be granted increased liability protection if they can demonstrate that they followed established clinical guidelines, according to a bill introduced in Congress this week.

The Saving Lives, Saving Costs Act, introduced by Reps. Andy Barr (R-KY) and Ami Bera (D-CA), would create a "safe harbor" for physicians who follow best practice guidelines. Physicians also could request that state-level malpractice suits be moved to federal courts.

"Rather than being directed by Washington, the guidelines will be developed by the physician community based on the best available scientific evidence," according to a joint statement by the legislators. "Guidelines should be developed through a transparent process by a knowledgeable, multidisciplinary panel of experts."

A physician who is being sued could "argue that he or she adhered to the relevant practice guidelines, which would cause a suspension in the proceedings while an independent medical review panel investigates."

If the panel determines that the physician conformed to the guidelines, or that failure to conform was neither the cause nor the proximate cause of the alleged injury, the case would be dismissed pending clear and convincing evidence that the medical review panel was in error, the statement said.

Physicians would be allowed to use the panel's findings as an affirmative defense in court. The bill also specifies that physicians whose care varies from guidelines are not automatically held liable.

"Congressman Bera and I introduced the Saving Lives, Saving Costs Act because there is nothing partisan about finding practical solutions to improve patient health outcomes," said Rep. Barr. "Americans deserve healthcare reform that will help lower the cost of care and protect the sacred patient–doctor relationship. Our bill will lead to better, more affordable, and evidence-based patient care by removing the need for physicians to worry about practicing defensive medicine, instead allowing them to focus on their patients' actual needs."

"The bipartisan Saving Lives, Saving Costs Act is a practical way to bring down the skyrocketing cost of healthcare and to make the system work better for patients that people from both parties can get behind," said Rep. Bera. "As a doctor, I know that physicians want to do what's best for their patients, and promoting evidence-based medicine will help us do that."

Professional medical organizations that have published clinical practice guidelines would submit them to the Secretary of Health and Human Services within 6 months of the bill's enactment. The secretary would then approve and publish the guidelines.

An independent medical review panel will be composed of 3 members who are experts in the relevant field of clinical practice. They would be approved by their specialty societies and reside in the same region where the case was brought, when possible.

Support, With Some Reservations

The American Congress of Obstetricians and Gynecologists (ACOG) applauded the proposed law and said it would "help avoid frivolous lawsuits and ensure that obstetrician-gynecologists can continue to treat their patients," ACOG said in a statement.

"Clinical practice guidelines, like those issued by ACOG, provide ob-gyns with top-quality recommendations based on scientific research and input from expert obstetrician-gynecologists," said ACOG President Jeanne A. Conry, MD, PhD. "It is essential that physicians who follow best practices in patient care be protected from liability."

The Physician Insurers Association of America (PIAA), which represents physician-run malpractice insurers, also endorsed the law's goals, but with some reservations. "We believe that the legislation raises concerns about whether the guidelines it envisions will provide adequate protection for both patients and providers in the long run," PIAA President and Chief Executive Officer Brian K. Atchinson told Medscape Medical News. "The bill also would potentially lengthen the claims adjudication process, thus delaying the resolution of claims and adding to the costs of the medical liability system. It is our feeling that this concept requires more vetting, and we are open to helping craft an improved bill."

The American Academy of Family Physicians (AAFP) is still reviewing the proposed law. "However, the AAFP has long supported medical liability reform.... The current system has failed both patients and the medical community," AAFP President Reid Blackwelder, MD, told Medscape Medical News. "Too few patients who are actually injured by medical care receive just compensation, while frivolous lawsuits, excessive damage awards, and exorbitant attorneys' fees push malpractice premiums up and prompt defensive medicine practices that increase the cost of health care."

The American Academy of Orthopaedic Surgeons (AAOS) said it supports the concept of a safe harbor for physicians who follow established and approved clinical practice guidelines. "While there is still a lot to do, this bill takes positive steps towards reducing medical malpractice and insurance fraud, which is important in ensuring that physicians can continue to provide the highest quality patient care," Tom Fleeter, MD, Chair, AAOS Medical Liability Committee, told Medscape Medical News.

The American Medical Association (AMA) doesn't have a position on the proposed law. AMA "supports proven liability reforms such as those enacted in California and Texas, as well as funding to test the effectiveness of innovative alternative liability reform proposals at the state level, including health courts, early offers and safe harbors for the practice of evidence based medicine," it said in a statement.

Wednesday, March 5, 2014

Canada TV News – Making a federal case out of Lyme Disease


Joanne Schnurr, CTV Ottawa                                     

Published Monday, March 3, 2014 5:10PM EST                           

Last Updated Monday, March 3, 2014 6:42PM EST             

A tiny bug is taking center stage at the House of Commons in Ottawa.  Lyme disease is a debilitating illness caused by a deer tick. Now, the Green Party's Elizabeth May is urging members to vote for a national strategy to fight and treat the disease.  Those suffering from this illness are anxiously awaiting the results.

It was a trip to a local lake 7 years ago that started Maureen Landry's journey through hell.

"I got a tick bite when I was at lac Philippe beach in august 2007," says Landry…

Watch CTV report

Tuesday, March 4, 2014

National Geographic Lyme Article

We should all be liking and sharing this article on Facebook as well as writing comments. This is an astounding article for NG to have printed and we need to show that there's a large readership for these kinds of articles.

Bob


Blacklegged ticks are known carriers of the pathogenic bacteria that causes Lyme disease.
PHOTOGRAPH BY JIM GATHANY, CDC/PHIL/CORBIS
Jarret Liotta
PUBLISHED FEBRUARY 28, 2014
Part of our weekly "In Focus" series—stepping back, looking closer.
Rampant disagreement over what constitutes Lyme disease—in particular, who may have contracted it and how, and how long it lasts—has spawned the larger question of how best to treat it. A new study pointing to the possibility of sexual transmission of the pathogen adds fuel to the fire.
Amid the uncertainty, a patient-led lobby (the counterculture, as someone has called it) that includes doctors as well as Lyme sufferers advocates a broader definition of the disease, both for treatment and insurance purposes.
But the medical establishment asserts that too liberal a definition—and what are seen as renegade practitioners—has led to irresponsible and potentially dangerous treatment of unrelated maladies misidentified as Lyme.
It's also unknown how many people have died because of Lyme. A 2011 study found that of the 114 deaths reported over a five-year period listing Lyme as a partial or direct cause, only one was consistent with clinical manifestations described by the International Classification of Diseases.
In December 2013, the Centers for Disease Control and Prevention (CDC) confirmed that Lyme carditis—a condition in which the Lyme bacterium infects the heart—caused three deaths over the past two years. Between 1985 and 2008, only four other fatal cases were confirmed.
While the course of the illness varies greatly from person to person, initial manifestations can include a unique skin lesion known aserythema chronicum migrans, headaches, musculoskeletal pain, coughing, sore throat, conjunctivitis, and minor neurological impairment.
If the diagnosis is confirmed early enough, Lyme is treated almost exclusively with short-term antibiotics, often penicillin, which are almost 100 percent effective. But if Lyme goes untreated, symptoms can progress. (Watch related video: "The Deer Tick")
In Lyme's second stage, typically between one and several months after the initial infection, neurological abnormalities can arise, such as meningitis, encephalitis, and cranial neuritis, which can manifest as facial palsy. Some patients develop cardiac problems.
In the third stage, which can take several months to years to show up, many patients develop chronic arthritis as well as an increase in neurological and cardiac symptoms, the severity of which can ebb and flow.
Voices in the counterculture argue that Lyme's symptoms are more intense and longer lasting than the medical establishment acknowledges. They say that symptoms of chronic Lyme disease are responsible for related deaths, including suicides from depression about the disease or from the trauma of persistent debilitating symptoms such as arthritis, heart problems, and cognitive impairment.
New Developments
And now, further complicating the picture, a study published this January contends that Lyme disease may be sexually transmitted. It shows that the Lyme pathogen, Borrelia burgdorferi (Bb), has been found in both male and female sexual secretions, raising the question of whether people are at risk through intimate contact.
Bb is one of only six known spirochete bacteria, named for their coiled spiral shape. (One of the six is the bacterium responsible for syphilis.)

PHOTOGRAPH BY SCIENCE PICTURE CO., CORBIS
Borrelia burgdorferi is the bacterial agent of Lyme disease.
The primary vector for Bb is the deer tick—Ixodes scapularis—although other kinds of ticks have been known to transmit it, and other insects, including some mosquitoes, carry the pathogen.
A study of Bb last year revealed that it's the first known organism that doesn't need iron to survive. This allows it to evade an iron-inhibiting hormone called hepcidin, produced by the liver, which can starve intrusive bacteria.
Instead, Bb thrives on manganese, which it uses to make essential enzymes for survival—something researchers who made the discovery last year believe could play a role in ultimately combating the pathogen.
Origins: Did Ötzi Have Lyme?
In 2012, a team of researchers claimed that the 5,300-year-old mummy known as Ã–tzi the Iceman, discovered along the Austria-Italy border in 1991, had contracted Lyme.
Some claim that the disease first appeared in Germany in the 1880s or France in the 1920s; others say it took root in the U.S. around the time of the Great Depression.
In the summer of 1975, 39 children living relatively close to one another in Lyme, Connecticut, were recognized as sharing common symptoms consistent with juvenile rheumatoid arthritis.
Polly Murray, whose 11-year-old son, Todd, was one of those affected, alerted the state health department after the local orthopedic doctor was stumped. "He had a different answer for everybody," says Todd, who is now 49.

PHOTOGRAPH BY THE BRIDGEMAN ART LIBRARY, GETTY
Ötzi the Iceman, a 5,300-year-old mummy, may have had Lyme disease.
As his mother began drawing attention to the strange epidemic, a doctor at Yale University named Allen Steere began sleuthing the problem.
In a 1977 paper in the medical journal Arthritis and Rheumatism, Steere identified a new disease transmitted by ticks. He called it Lyme arthritis, and soon after it became known as Lyme disease.
Lyme ticks are active year-round, other than during subfreezing weather, but spring is the most dangerous season. That's when the baby ticks, or nits—so tiny as to be almost invisible—are born.
One theory—compelling but controversial—about the sudden emergence of the disease in Connecticut blames the accidental release of infected ticks during experiments at Plum Island Animal Disease Center, on Long Island Sound about eight miles south of Lyme.
Originally operated by the U.S. Army, then by the Department of Agriculture, and now by the Department of Homeland Security, the facility's official mandate is defense research relating to agricultural bioterrorism.
A book by Michael Carroll called Lab 257 cites post-World War II experiments on Plum Island that involved using ticks as disease vectors for germ warfare.
Officials have denied the allegations, but Carroll and others—including former Minnesota Gov. Jesse Ventura—allege the government has used the facility to develop various diseases intended for delivery as biological weapons.
When Is Lyme Lyme?
For his discovery of Lyme and subsequent work on the disease, Allen Steere started out as the counterculture's golden boy. But he came to believe that too many symptoms were being labeled chronic Lyme without proof. He says he's now a pariah to advocacy groups and Lyme sufferers, and he avoids involvement in the increasingly polarized controversy.
Gary Wormser, head of infectious diseases at New York Medical College in Valhalla, agrees that misdiagnosis of Lyme is rampant. "I don't think it's helping patients. I don't think it's helping science," he says.
Lyme, Wormser says, has become a catchall for a constellation of symptoms that elude diagnosis: "If I can't figure out what you have, it must be Lyme disease."
He puts some of the blame on medical science's failure to find answers to a range of symptoms that include headaches, joint and muscle aches, depression, chronic fatigue, irritable bowel syndrome, and cognitive impairment. These ailments often seem to be subjective, with no physiological cause.
"For a lot of people who are not feeling well, those people are the most vulnerable to turning to the types of practitioners that don't follow mainstream practices," Wormser says.
"I'm not saying there aren't some [Lyme] patients that have been debilitated by some of these symptoms, but it seems to be a really small percentage—far less than you'd be led to believe."
Todd Murray, one of the original Lyme children, grew up to be an emergency department physician. He believes he still suffers from symptoms relating to the original infection.
"I have weird things I attribute to Lyme," he says, including a permanent heart condition diagnosed in 1989.
As a doctor, Murray recognizes the dilemma of anecdotal evidence. "I can see both sides, because physicians have to go on evidence-based medicine. So to try to use therapies which have not been shown to be beneficial in clinical studies doesn't make sense."
He cites, for instance, hormone replacement therapy for post-menopausal women, which was ultimately shown to increase coronary artery disease, stroke, and breast cancer. "A lot of things in medicine would seem to intuitively make sense. However, when they're studied, the outcomes may be found to be different than expected," Murray says.
Challenges of Treatment
Identification of Lyme usually begins with the telltale bull's-eye rash. But patients don't always present with the rash, or sometimes it has a different shape and appearance, which means the disease can progress before a course of antibiotics is prescribed.
In Lyme's later stages, antibiotics are still used, with dosages and duration increased. But there's disagreement as to whether antibiotics should ever be administered for longer than three months, even in extreme cases.
"The ideology of the counterculture," Steere says, "is to simply treat symptoms with antibiotic therapy, [and] the Infectious Diseases Society of America [IDSA] has said in essence that's not correct." The IDSA notes that "using antibiotics for a very long time [months or years] does not offer superior results and in fact can be dangerous, because it can cause potentially fatal complications."

PHOTOGRAPH BY KALLISTA IMAGES, GETTY
Lyme disease is often accompanied by a bull's-eye rash.
Counterculture doctors treating patients whom they believe have chronic Lyme will recommend not only long-term antibiotic treatment but also various other therapies, such as holistic curatives, physical therapy, and counseling.
Because some people who have Lyme elude detection, "you have to ask the right questions when you make a diagnosis," Murray says. "I think there needs to be a standardized, reliable protocol for testing."
Culturing the Lyme spirochete, Bb, to determine the presence of Lyme would provide a definitive answer. But it's costly and time-consuming, and therefore rarely done.
Instead doctors usually check for the presence of Lyme antibodies through a blood test. According to the CDC's recommendations, if the test, known as an enzyme-linked immunosorbent assay (ELISA), proves negative for the antibodies, no further test is recommended. If it comes up positive, a second test—an immunoblot test—is recommended to confirm Lyme.
Murray says ELISA and blots in tandem are currently the best method, along with more complicated cerebrospinal fluid tests in cases where symptoms are apparent but the first two tests are negative.
But with these methods, false negatives are still a significant possibility. It's also possible that Lyme cells can alter their outer surface protein and escape detection, and that different spirochetes can cause symptoms that look like Lyme but aren't. All this, Murray says, means research must be targeted toward finding better tests for the disease.
Follow the Leaders—Or Off With Your Head!
Daniel Cameron, president of the International Lyme and Associated Diseases Society, speaks for the counterculture. He believes that "thought leaders" in the medical community prevent acceptance of what he considers strong evidence that Lyme is both underreported and ineffectively treated. "Who wants to question Dr. Wormser?" he says.
"Even though the evidence is accumulating [that Lyme can be chronic], doctors have a tendency to have to wait for a thought leader to change their mind, otherwise they'll get criticized, or the medical board might drop the ax on you," he says. "Off with your head! So it becomes high risk to become a doctor who treats chronic Lyme. Most doctors don't want to have to."

PHOTOGRAPH BY JEFFREY PHELPS, AURORA PHOTOS/CORBIS
Ticks are easily picked up on hikes through wooded areas, like the trails seen here in Parfrey's Glen in Wisconsin.
Cameron says many state medical boards are pursuing lengthy "chart-by-chart" investigations of doctors using long-term antibiotic treatment for Lyme. These can continue for years prior to legal action by boards aimed at revoking a doctor's license.
But five states—California, Connecticut, Massachusetts, New Hampshire, and Rhode Island—have passed laws protecting physicians from reprisal or harassment when treating Lyme patients with long-term antibiotics.
While he's careful not to use the word "cure," Cameron says that with long-term treatment, patients who have had Lyme for years can go into remission and be symptom-free.
He's not particularly impressed with the CDC's latest announcement that the number of Lyme cases in the U.S. is likely ten times the 30,000 or so generally reported each year.
"In epidemiology, every time you have a surveillance system, you always at least have a tenfold underreporting. There have been studies that show it might be as much as 40 times that."
He also questions the fact that 95 percent of the reported cases come from just 13 states, mostly in the Northeast, along with Minnesota, Virginia, and Wisconsin. People in other states are less likely to report cases if the official view is that Lyme is rare and geographically restricted, according to Cameron. "That's a little bit of a reporting problem."
Could the CDC's admission of greater numbers be related to the preparation of a new Lyme vaccine?
"They had one vaccine," Cameron says—LYMErix, which was available for about five years until 2002. It was then shelved because of low sales and, some say, questionable effectiveness. (Ironically, Lyme vaccines are available for dogs but not humans.)
"The buzz on the street is that, of course, one of the reasons the CDC recognized more cases is that in order to get a vaccine through the pipeline, you have to have a problem," Cameron says.
Game Changer
Raphael Stricker, a San Francisco–based internist who co-led the sexual transmission study, says the possibility of Lyme spreading that way would "change the whole picture." It means that potentially ticks aren't the only culprits.
"What I think this is going to do is that it's going to move treatment to another level," he says.
Jarret Liotta is a freelance writer. Follow him on Twitter.

Sunday, March 2, 2014

Brake for Opossums - they fight Lyme



The Virginia opossum is not the brightest of animals. When they are threatened, they pretend to be dead, which is where we get the expression "playing possum." Sometimes, they do this in response to threats from oncoming traffic, which results in possums becoming roadkill.
 

The next time you see a possum playing dead on the road, try your best to avoid hitting it. Because it turns out that possums are allies in the fight against Lyme disease.

Possums, like many other small and medium sized mammals, are hosts for ticks looking for a blood meal. But possums are remarkably efficient at eliminating foraging ticks.

"In a way, opossums are the unsung heroes in the Lyme Disease epidemic."

Rick Ostfeld, author of a book on Lyme disease ecology and a senior scientist at the Cary Institute of Ecosystem Studies, explains...

"Because many ticks try to feed on opossums and few of them survive the experience. Opossums are extraordinarily good groomers it turns out – we never would have thought that ahead of time – but they kill the vast majority – more than 95% percent of the ticks that try to feed on them. So these opossums are walking around the forest floor, hoovering up ticks right and left, killing over 90% of these things, and so they are really protecting our health."

So it's in our best interest to have possum neighbors. This means keeping their habitat intact with thoughtful land use planning, tolerating them in our yards, and, whenever possible, avoiding possum collisions.

Source:

Why you should brake for possums


Produced in collaboration with WAMC Northeast Public Radio, this podcast originally aired on July 23, 2012. To access a full archive of Earth Wise podcasts, visit: www.earthwiseradio.org.